GTHX
Price
$4.32
Change
-$0.15 (-3.36%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
IGMS
Price
$9.65
Change
+$0.38 (+4.10%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
Ad is loading...

GTHX vs IGMS ᐉ Comparison: Which is Better to Invest?

Header iconGTHX vs IGMS Comparison
Open Charts GTHX vs IGMSBanner chart's image
G1 Therapeutics
Price$4.32
Change-$0.15 (-3.36%)
Volume$603.92K
CapitalizationN/A
IGM Biosciences
Price$9.65
Change+$0.38 (+4.10%)
Volume$152.95K
CapitalizationN/A
View a ticker or compare two or three
GTHX vs IGMS Comparison Chart

Loading...

GTHXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IGMSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GTHX vs. IGMS commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTHX is a Hold and IGMS is a Buy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (GTHX: $4.32 vs. IGMS: $9.65)
Brand notoriety: GTHX and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GTHX: 63% vs. IGMS: 83%
Market capitalization -- GTHX: $225.5M vs. IGMS: $567.29M
GTHX [@Biotechnology] is valued at $225.5M. IGMS’s [@Biotechnology] market capitalization is $567.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTHX’s FA Score shows that 0 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • GTHX’s FA Score: 0 green, 5 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, GTHX is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTHX’s TA Score shows that 6 TA indicator(s) are bullish while IGMS’s TA Score has 4 bullish TA indicator(s).

  • GTHX’s TA Score: 6 bullish, 4 bearish.
  • IGMS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GTHX is a better buy in the short-term than IGMS.

Price Growth

GTHX (@Biotechnology) experienced а +16.76% price change this week, while IGMS (@Biotechnology) price change was -5.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

GTHX is expected to report earnings on May 01, 2024.

IGMS is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for GTHX with price predictions.
OPEN
A.I.dvisor published
a Summary for IGMS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IGMS($567M) has a higher market cap than GTHX($226M). GTHX YTD gains are higher at: 41.639 vs. IGMS (16.125). GTHX has higher annual earnings (EBITDA): -34.3M vs. IGMS (-255.18M). IGMS has more cash in the bank: 338M vs. GTHX (82.2M). IGMS has less debt than GTHX: IGMS (40.5M) vs GTHX (55.9M). GTHX has higher revenues than IGMS: GTHX (82.5M) vs IGMS (2.13M).
GTHXIGMSGTHX / IGMS
Capitalization226M567M40%
EBITDA-34.3M-255.18M13%
Gain YTD41.63916.125258%
P/E RatioN/AN/A-
Revenue82.5M2.13M3,873%
Total Cash82.2M338M24%
Total Debt55.9M40.5M138%
FUNDAMENTALS RATINGS
GTHX: Fundamental Ratings
GTHX
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GTHXIGMS
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
GTHXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IGMSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTTX28.310.04
+0.14%
Fidelity Advisor Biotechnology M
SAPCX32.630.03
+0.09%
ClearBridge Appreciation C
MGFAX10.20N/A
N/A
MassMutual Global A
SLFYX7.79N/A
N/A
SEI Multi-Asset Inflation Mgd Y (SIMT)
TGREX11.84N/A
N/A
TCW Global Real Estate I

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with CRSP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+4.10%
CRSP - IGMS
48%
Loosely correlated
-2.85%
MDGL - IGMS
42%
Loosely correlated
+3.18%
BTAI - IGMS
37%
Loosely correlated
-2.08%
NTLA - IGMS
37%
Loosely correlated
+1.67%
FATE - IGMS
36%
Loosely correlated
N/A
More